Showing 4 of 4 recruiting trials for “occult-macular-dystrophy”
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
RecruitingNCT06805474 ↗
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
RecruitingNCT05809635 ↗
Study of BEST1 Vitelliform Macular Dystrophy
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →